IHH Healthcare Berhad

What IHH Healthcare Berhad does

IHH Healthcare Berhad is a Kuala Lumpur-headquartered private healthcare services operator, publicly listed on Bursa Malaysia and the Singapore Exchange, that runs an integrated network of 89 hospitals and nearly 190 healthcare facilities across 10 countries spanning Malaysia, Singapore, Türkiye, India, China, Hong Kong, Brunei, and Central/Eastern Europe (Bulgaria, North Macedonia, Netherlands, Serbia). The Group delivers acute care from primary through quaternary levels — including oncology, cardiology, organ transplants, neurosurgery, and rehabilitation — under a portfolio of premium hospital brands (Acibadem, Gleneagles, Mount Elizabeth, Parkway, Fortis, Pantai, Prince Court, Island Hospital) and serves individual patients, corporate clients/insurers, specialty patients, and international medical tourists. It employs approximately 76,000 professionals and treats millions of patients annually (over 5 million in Türkiye and Europe alone).

Revenue is generated primarily through patient treatments, procedures, admissions, and specialist consultations at owned hospitals and clinics, supplemented by diagnostics (over 400 Agilus laboratories in India, Parkway Laboratories, Premier Integrated Labs), ancillary services (radiology, rehabilitation, pharmacy, third-party administration via iXchange), and medical tourism referral networks (61 Acibadem Healthpoints across 33 countries; 35+ patient assistance centres for Singapore). Pricing for clinical care is quote-based and not publicly disclosed; only ancillary items such as ethics-committee review fees in Singapore are published. Go-to-market is enterprise field-sales driven, combining direct patient referrals, corporate partnerships, insurance/TPA networks, and international patient programmes.

The company invests heavily in capital-intensive medical technology (Da Vinci robotics, Gamma Knife, PET-CT, LINAC, CyberKnife, MRI Linac) and is layering digital and AI capabilities: a seven-year Infosys contract to build an AI-driven ERP consolidating procurement across ~190 facilities, AI-enabled operations at Mount Elizabeth (claims processing, theatre scheduling, bed management, nurse rostering), ROBIE autonomous logistics robots at Acibadem Maslak, TibaRay flash radiotherapy investment, and patient platforms MyHealth360 and LizWorld. IHH has grown through sustained M&A, most recently completing its acquisition of India's Fortis Healthcare in November 2025 via subsidiary Northern TK Venture.

Name

IHH Healthcare Berhad

Legal name

IHH Healthcare Berhad

Website

https://ihhhealthcare.com

Company type

Public

Founded year

1974

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

IHH Healthcare is a Malaysia-based, dual-listed private healthcare operator running 89 hospitals and ~190 facilities across 10 countries, serving individual, specialty, corporate/insurer, and international medical-tourism patients under premium brands including Acibadem, Gleneagles, Mount Elizabeth, Parkway, and Fortis.

Ownership category

akta.pro rank

Product category

Private Hospital & Healthcare Services

NAICS

General Medical and Surgical Hospitals (6221)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062)

akta.pro primary industry

Community & Regional General Hospitals (HLAFAAAB)

akta.pro secondary industries

Virtual Specialty Care Platforms (tele-stroke, tele-ICU, tele-derm, tele-cardiology) (HLALABAD), Primary Care & General Medicine Virtual Care (Employer-Sponsored) (HLALADAA)

Keywords

• Private hospital services
• Diagnostic laboratory services
• Primary care clinics
• Medical tourism services
• Tertiary healthcare

Headquarters

HQ city

Kuala Lumpur

HQ country

Malaysia

HQ region

Asia

Offices6 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Hospital and Healthcare Services: IHH generates revenue primarily through its integrated network of hospitals, clinics, and ambulatory care centres offering medical services across 10 countries. Revenue is derived from patient treatments, procedures, hospital admissions, and specialist consultations.
2. Diagnostics Services: Diagnostics revenue from laboratory networks including over 400 Agilus Diagnostics laboratories in India, Parkway Laboratories in Singapore and Hong Kong, and Premier Integrated Labs in Malaysia.
3. Ancillary Healthcare Services: Revenue from ancillary services including radiology, rehabilitation, pharmacy, and third-party administration through brands such as Parkway Radiology, Parkway Rehab, Premier Integrated Rehab, and iXchange.
4. Medical Tourism and International Patient Services: Revenue from international medical tourists, with 61 Healthpoint representative offices in 33 countries and 57 cities facilitating patient referrals to Türkiye's Acibadem facilities.

Pricing tiers

Go-to-market motion1 record

Distribution channels7 records

Marketing channels8 records

Core offering

IHH Healthcare Berhad operates one of the world's largest private healthcare services networks, delivering tertiary and quaternary hospital care, primary care, diagnostics, rehabilitation, and ancillary medical services through 89 hospitals and over 190 facilities across 10 countries. Its portfolio spans premium hospital brands (Acibadem, Gleneagles, Mount Elizabeth, Parkway, Fortis, Pantai, Prince Court), diagnostic laboratory networks (Agilus, Parkway Labs, Premier Integrated Labs), primary care clinics, and digital patient platforms such as MyHealth360.

Product overview

IHH Healthcare Berhad operates as a diversified healthcare platform offering acute care hospital services, primary care clinics, diagnostics, rehabilitation, and specialized services across 10 countries. The portfolio includes flagship hospital brands (Acibadem, Gleneagles, Mount Elizabeth, Fortis, Pantai, Parkway, Prince Court, Island Hospital, Timberland Medical Centre), diagnostic services (Agilus Diagnostics, Premier Integrated Labs, Parkway Laboratory Services), rehabilitation (Premier Integrated Rehab, Pantai Integrated Rehab), and technology-enabled platforms (MyHealth360 patient portal, LizWorld, ROBIE autonomous robots, AI-driven ERP with Infosys, TibaRay radiotherapy). The company operates 89 hospitals with nearly 190 healthcare facilities total, supported by a seven-year AI-driven ERP platform deal with Infosys, autonomous logistics robots at Acibadem facilities, and ERAS surgical recovery programmes across the network.

Differentiator

Problem solved

Functional benefit

Brands

• Acibadem: Hospital and healthcare services brand operating in Türkiye and Europe
• Gleneagles
• Mount Elizabeth
• Prince Court
• Fortis
• Pantai
• Parkway
• Island Hospital
• Timberland Medical Centre
• Twin Towers Medical Centre
• IHH Laboratories
• MyHealth360
• Agilus Diagnostics
• Premier Integrated Labs
• Premier Integrated Rehab

Products and services

• Acibadem Hospitals Network of 24 hospitals and 18 medical centres in Türkiye, Bulgaria, North Macedonia, Netherlands, and Serbia offering tertiary and quaternary care including oncology (MRI Linac, Gamma Knife ICON, CyberKnife, Truebeam), organ transplant, cardiology, and robotic surgery. Targets both local and international medical tourism patients.
• Gleneagles Hospitals International hospital network across Singapore, Malaysia, Hong Kong, India, and China offering comprehensive tertiary medical care across multiple specialties. Gleneagles Hospital Singapore runs an Enhanced Recovery After Surgery (ERAS) programme that cut average length of stay for knee replacement from 4 days to 2 days.
• Mount Elizabeth Hospitals Two flagship private hospitals in Singapore (Mount Elizabeth and Mount Elizabeth Novena) with over 40 years of legacy, completed Project Renaissance transformation featuring AI-enabled operations, redesigned wards, the LizWorld patient platform, and over 1,500 accredited specialists across the cluster.
• Parkway Hospitals Parkway hospital network in Singapore (including Parkway East Hospital) and Parkway Shanghai Hospital — a 450-bed tertiary care hospital opened in 2023 — providing cardiology, cardiac surgery, gastroenterology, urology, minimally invasive surgery, and internal medicine services.
• Fortis Healthcare Hospitals 27 Fortis hospitals and 6 Gleneagles Hospitals in India with about 4,100 operational beds and over 400 diagnostics centres. Leading provider of organ transplants, oncology, cardiology, and neurosurgery. Fortis Memorial Research Institute (FMRI) launched India's first Centre of Excellence for Myeloma and Lymphoma offering CAR-T, stem cell transplantation, and precision medicine.
• Pantai Hospitals 11 Pantai Hospitals across Malaysia providing quality private care for over 50 years, supported by more than 2,822 consultants and 14,000+ staff in IHH Malaysia.
• Prince Court Medical Centre Premium medical centre in Kuala Lumpur delivering personalised private healthcare to individual and corporate patients.
• Island Hospital and Timberland Medical Centre Island Hospital (Penang, established 1996) and Timberland Medical Centre (82-bed hospital in Kuching, Sarawak with 30-year legacy) provide comprehensive medical and surgical services to Malaysian patients.
• Agilus Diagnostics Largest network of NABL-accredited diagnostic labs in India, with over 400 laboratories covering more than 1,000 towns and cities across 25 states and 5 union territories. Serves referring physicians, hospitals, and direct patients.
• Parkway Shenton Primary Care Network of over 30 primary care clinics island-wide in Singapore providing comprehensive outpatient services to individual patients and corporate clients.
• Parkway Laboratory Services and Premier Integrated Labs Laboratory and diagnostic services in Singapore, Hong Kong, and Malaysia (Parkway Laboratory Services, Parkway Labs, Premier Integrated Labs) serving diverse healthcare facilities and patients.
• Parkway Specialty Services (Cancer, Radiology, Rehabilitation) Specialty care lines across the IHH network including Parkway Cancer Centre, Parkway Radiology, Parkway Rehab (Singapore), and Premier Integrated Rehab / Pantai Integrated Rehab (Malaysia) supporting oncology, imaging, and rehabilitation patients.
• iXchange Third-Party Administration Third-party administration and managed care services in Singapore providing integrated employee benefits administration and claims management for corporate clients and insurers.
• MyHealth360 Digital Health Platform Digital patient platform enabling access to medical records, reports, diagnostic images, and health management services across IHH facilities.
• LizWorld Patient Experience Platform Patient platform at Mount Elizabeth Hospital integrating digital wayfinding, in-room services, patient information, and self-service requests into one experience.
• Integrated Chinese and Western Medicine Health Management Services Integrated Chinese and Western medicine services launched at Parkway MediCentre Xintiandi in Shanghai, including acupuncture, specialised Tuina, herbal treatments, and integrated medicine management through the Qian Yiming and Sun Wuquan Workstations.
• MSK Care Pathway

Quantifiable outcome

• Over 5 million patients treated annually across Türkiye and Europe alone
• +4 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature4 records

Partnerships

17 partnerships are on record, tiered minor and core.

• Yueyang Hospital of Integrated Traditional Chinese and Western MedicineminorStrategic or Co-development Partner · 18 June 2026Parkway MediCentre Xintiandi in Shanghai partnered with Yueyang Hospital of Integrated Traditional Chinese and Western Medicine and Shanghai University of Traditional Chinese Medicine to launch integrated Chinese and Western medicine services. Key highlights include the unveiling of the Qian Yiming Integrated Traditional Chinese and Western Medicine Workstation and Sun Wuquan Tuina Workstation.
• Shanghai University of Traditional Chinese MedicineminorStrategic or Co-development Partner · 18 June 2026Co-organised the integrated Chinese and Western medicine health management event with Parkway Shanghai, serving as a platform for cultural exchange and collaboration with leading academic and clinical partners.
• Rumah Sakit ParikesitminorStrategic or Co-development Partner · 10 June 2026Gleneagles JPMC partnered with Rumah Sakit Parikesit to conduct cardiac care knowledge sharing sessions, including clinical discussions and a heart health awareness session at Bank Danamon in Samarinda.
• InfosyscoreTechnology or Integration · 4 June 2026IHH Healthcare awarded Infosys a seven-year contract to develop and deploy an AI-driven enterprise resource planning (ERP) platform consolidating purchases across its global network of nearly 190 facilities in 10 countries. Industry experts estimate the deal could be worth a few hundred million dollars. This project represents the first step toward potential broader outsourcing of IHH's finance and accounting functions.
• TibaRaycoreStrategic or Co-development Partner · 2 February 2026IHH Healthcare invested in US-based TibaRay to acquire advanced flash radiotherapy technology for its oncology services. The TibaRay Phaser proton therapy machine can treat patients up to 400 times faster than conventional radiotherapy, reducing radiation exposure by 20% to 30%. Target pricing is expected to be in line with or slightly above conventional linear accelerator machines costing about US$5 million each. MBSB Research maintained a 'neutral' call on IHH with a target price of RM8.25.
• Blue Cross (Hong Kong)coreStrategic or Co-development Partner · 1 January 2026Gleneagles Hospital Hong Kong is a hospital partner in Blue Cross' newly launched MSK Care Pathway, forming an integrated network spanning multiple healthcare institutions across Hong Kong and the Greater Bay Area. The initiative simplifies the MSK care journey for patients from diagnosis to treatment, surgery and rehabilitation.
• Bank DanamonminorGTM or Marketing Partner · 1 January 2026Gleneagles JPMC conducted a heart health awareness session at Bank Danamon in Samarinda for priority banking clients and staff, demonstrating community outreach and health education.
• China Hong Kong Paralympic CommitteeminorGTM or Marketing Partner · 1 January 2026Gleneagles Hong Kong served as title sponsor of the 2nd Classification Conference cum Workshop organised by the China Hong Kong Paralympic Committee to advance para sports development in Hong Kong.
• Hong Kong, China Sports Association for Persons with Intellectual DisabilityminorGTM or Marketing Partner · 1 January 2026Gleneagles Hong Kong partnered with the Hong Kong, China Sports Association for Persons with Intellectual Disability to provide free health and vision screenings for students with intellectual disability, supporting safe sports participation.
• ERAS SocietycoreStrategic or Co-development Partner · 1 January 2026Gleneagles Hospital Johor became the first hospital in Malaysia to achieve ERAS Qualification in Knee Arthroplasty from the ERAS Society, demonstrating evidence-based surgical recovery protocols. Gleneagles Hospital Singapore was also recognised for early ERAS adoption in Singapore's private healthcare sector.
• MBSB ResearchminorOthers · 1 January 2026MBSB Research maintained a 'neutral' call on IHH Healthcare with an unchanged target price of RM8.25, noting that the TibaRay investment positions IHH as a premium, competitive provider of advanced oncology technologies.
• Wira Transplant MalaysiaminorGTM or Marketing Partner · 1 January 2026IHH Healthcare Malaysia supported Wira Transplant Malaysia in the 'Climbing Kinabalu for Hope and Organ Donation Awareness' expedition led by The ResilientMan (Siva Kumar Raghavan) and Manvir Victor, helping assess climber health before and after the expedition.
• Singapore Business Federation (VolunteerInc)minorGTM or Marketing Partner · 1 January 2026IHH Healthcare participated in the launch of VolunteerInc at the Future Economy Conference, joining as one of the first 50 corporates in this Singapore Business Federation initiative to strengthen corporate volunteerism and community impact.
• Singapore Red CrossminorGTM or Marketing Partner · 1 January 2024IHH Singapore conducts quarterly blood donation drives in partnership with the Singapore Red Cross since 2021, demonstrating commitment to community health and corporate social responsibility.
• Para Athletics Singapore (PAS)coreStrategic or Co-development Partner · 1 January 2024IHH Healthcare Singapore signed a two-year MOU with Para Athletics Singapore to improve the healthcare experience of local para-athletes. IHH Singapore is committing to sponsor 60 physiotherapy sessions, 24 occupational therapy sessions, 12 podiatry sessions, diagnostic imaging, and annual blood tests. This is the first collaboration between PAS and a healthcare provider.
• Autism Resource Centre (ARC)minorStrategic or Co-development Partner · 2 October 2023IHH Healthcare Singapore and Autism Resource Centre (ARC) signed an MOU to train and empower individuals on the autism spectrum to gain employment in healthcare. The partnership with ARC and the Employability and Employment Centre (E2C) trains suitable clients for roles in the healthcare industry. To date, 19 ARC clients have been employed across IHH Singapore.
• Acibadem Acquisition of Acibadem Sistina (North Macedonia)coreStrategic or Co-development Partner · 1 January 2021Acibadem expanded its footprint through acquisitions, including North Macedonia in 2011, Bulgaria in 2016, Netherlands in 2017, and Serbia in 2021, establishing a pan-European healthcare network.

Scale indicators14 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• HCA Healthcare: Largest for-profit hospital operator in the US with ~190 hospitals and ambulatory centres. Comparable to IHH in scale, mix of tertiary care and ambulatory services, and focus on operational efficiency at multi-site hospital networks.
• Fresenius SE & Co. KGaA: Global healthcare conglomerate with hospitals (Helios) plus dialysis, pharma, and medical devices. Comparable in scale and international hospital operations, though IHH is more hospital-pure and Asia-anchored.

Direct peers

• KPJ Healthcare Berhad: Malaysia's largest homegrown private hospital chain. Overlaps directly with IHH's Pantai/Prince Court/Gleneagles footprint in Malaysia on patient segments, pricing, and insurance/employer relationships.
• Ramsay Health Care: Australia-listed hospital operator with large footprints in Australia, the UK, and continental Europe. Comparable to IHH in cross-border multi-brand hospital operations, tertiary acute care focus, and exposure to private-pay and insured patients.
• Raffles Medical Group: Singapore-listed integrated private healthcare provider with hospitals, primary care network, and health insurance. Comparable to IHH Singapore (Mount Elizabeth/Gleneagles/Parkway Shenton) on premium domestic and international patient services.
• Max Healthcare Institute: India-focused premium private hospital network concentrated in North India. Overlaps with IHH/Fortis on tertiary care complexity, doctor-led model, and hospital expansion in Indian metros.
• Bangkok Dusit Medical Services (BDMS): Thailand's largest private hospital network with 50+ hospitals across multiple brands. Closest Asian comparable to IHH in scale, multi-brand portfolio, and mix of domestic plus medical-tourism patients.
• Mediclinic International: Operator of private hospitals in Southern Africa, the UAE, and (historically) Europe. Closest peer to IHH's Acibadem European footprint in cross-border hospital operations, premium positioning, and tertiary service mix.
• Apollo Hospitals Enterprise: India's leading private hospital chain with strong tertiary and quaternary care, diagnostics, and pharmacy retail. Directly comparable to IHH's Fortis/Gleneagles India platform in clinical scope, medical tourism, and Indian private-pay dynamics.
• Bumrungrad Hospital Public Company Limited: Bangkok-based premium private hospital operator widely regarded as a global medical tourism hub. Directly comparable to IHH's Mount Elizabeth/Gleneagles/Acibadem model in patient mix, international patient services, and premium tertiary care positioning across Asia.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@CareForGood
• Facebookfacebook.com/ihhhealthcare
• LinkedInlinkedin.com/company/ihh-healthcare-berhad

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries14 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A4 records

Investments6 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IHH Healthcare Berhad